Eve Burstein
Stock Analyst at Bernstein
(0.98)
# 2,759
Out of 4,413 analysts
13
Total ratings
37.5%
Success rate
-14.39%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.69 | +47.93% | 2 | Apr 18, 2024 | |
| NTRA Natera | Upgrades: Outperform | $120 | $94.15 | +27.46% | 2 | Apr 5, 2024 | |
| TMO Thermo Fisher | Downgrades: Market Perform | n/a | $574.99 | - | 2 | Jan 8, 2024 | |
| EXAS Exact Sciences | Initiates: Outperform | $83 | $60.01 | +38.31% | 1 | Sep 28, 2023 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $24.42 | -9.91% | 1 | Sep 28, 2023 | |
| GH Guardant Health | Initiates: Outperform | $34 | $18.26 | +86.20% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $124.68 | -10.97% | 1 | Sep 28, 2023 | |
| WAT Waters | Initiates: Market Perform | $280 | $315.92 | -11.37% | 1 | Sep 28, 2023 | |
| A Agilent Technologies | Initiates: Market Perform | $123 | $138.69 | -11.31% | 1 | Sep 28, 2023 | |
| RVTY Revvity | Initiates: Outperform | $133 | $102.60 | +29.63% | 1 | Sep 28, 2023 |
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.69
Upside: +47.93%
Natera
Apr 5, 2024
Upgrades: Outperform
Price Target: $120
Current: $94.15
Upside: +27.46%
Thermo Fisher
Jan 8, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $574.99
Upside: -
Exact Sciences
Sep 28, 2023
Initiates: Outperform
Price Target: $83
Current: $60.01
Upside: +38.31%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $24.42
Upside: -9.91%
Guardant Health
Sep 28, 2023
Initiates: Outperform
Price Target: $34
Current: $18.26
Upside: +86.20%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $124.68
Upside: -10.97%
Waters
Sep 28, 2023
Initiates: Market Perform
Price Target: $280
Current: $315.92
Upside: -11.37%
Agilent Technologies
Sep 28, 2023
Initiates: Market Perform
Price Target: $123
Current: $138.69
Upside: -11.31%
Revvity
Sep 28, 2023
Initiates: Outperform
Price Target: $133
Current: $102.60
Upside: +29.63%